Antitumor and normal cell protective effect of PKC412 in the athymic mouse model of ovarian cancer

Medicine and Dentistry

• Cells 100%
• Ovarian Cancer 100%
• Paclitaxel 90%
• Tumor Necrosis Factor 54%
• Neoplasm 27%
• Cytokine Production 27%
• Tumor Regression 18%
• Incidence 9%
• Disease 9%
• T Cell 9%
• Growth 9%
• Cell Proliferation 9%
• Cytotoxicity 9%
• Immunosuppressive Treatment 9%
• Group Therapy 9%
• Side Effect 9%
• Flow Cytometry 9%
• Staurosporine 9%
• Body Weight 9%
• Weight Loss 9%
• Cancer Cell 9%
• Carcinogenesis 9%
• Protein Kinase C 9%

Biochemistry, Genetics and Molecular Biology

• Nude Mouse 100%
• Mouse Model 100%
• Mouse 45%
• Cytokine Production 27%
• Cell Proliferation 9%
• Staurosporine 9%
• Incidence 9%
• Cancer Cell 9%
• Growth 9%
• Tumor Volume 9%
• Weight 9%
• Cytotoxicity 9%
• Body Weight 9%
• Flow Cytometry 9%
• Protein Kinase C 9%
• Splenocyte 9%

Immunology and Microbiology

• Cells 100%
• Mouse Model 100%
• Mouse 45%
• Cytokine Production 27%
• Immunosuppression 9%
• Growth 9%
• Flow 9%
• Cell Proliferation 9%
• Splenocyte 9%
• Cancer Cell 9%
• Cytotoxicity 9%
• Incidence 9%
• Weight 9%
• Tumor Volume 9%
• Body Weight 9%